KP Tissue Inc (TSX:KPT)

C$ 8.4 0.06 (0.72%) Market Cap: 83.73 Mil Enterprise Value: 83.73 Mil PE Ratio: 12.13 PB Ratio: 1.18 GF Score: 34/100

Q1 2024 KP Tissue Inc Earnings Call Transcript
May 14, 2024

C$8.2 (-0.36%)

Earnings
Q3 2023 KP Tissue Inc Earnings Call Transcript
Nov 08, 2023

C$9.68 (+3.53%)

Earnings
Q2 2023 KP Tissue Inc Earnings Call Transcript
Aug 10, 2023

C$10.47 (-1.13%)

Earnings
Q1 2023 KP Tissue Inc Earnings Call Transcript
May 11, 2023

C$10.27 (+0.98%)

Earnings
Q4 2022 KP Tissue Inc Earnings Call Transcript
Mar 09, 2023

C$10.35 (+0.19%)

Earnings
Q3 2022 KP Tissue Inc Earnings Call Transcript
Nov 09, 2022

C$10.3 (+1.08%)

Earnings
Q2 2022 KP Tissue Inc Earnings Call Transcript
Aug 11, 2022

C$10.88 (-0.18%)

Earnings
Q1 2022 KP Tissue Inc Earnings Call Transcript
May 12, 2022

C$10.53 (-8.12%)

Earnings
Q4 2021 KP Tissue Inc Earnings Call Transcript
Mar 10, 2022

C$10.8 (+0.84%)

Earnings
Q3 2021 KP Tissue Inc Earnings Call Transcript
Nov 12, 2021

C$10.56 (-2.67%)

Earnings
Q2 2021 KP Tissue Inc Earnings Call Transcript
Aug 12, 2021

C$10.24 (-0.58%)

Earnings
KP Tissue Inc Annual Shareholders Meeting Transcript
Jun 09, 2021
Q1 2021 KP Tissue Inc Earnings Call Transcript
May 07, 2021

C$10.3 (+0.59%)

Earnings
Q4 2020 KP Tissue Inc Earnings Call Transcript
Mar 11, 2021

C$11.17 (-1.41%)

Earnings
Q3 2020 KP Tissue Inc Earnings Call Transcript
Nov 05, 2020

C$12.13 (-0.25%)

Earnings
Q2 2020 KP Tissue Inc Earnings Call Transcript
Aug 06, 2020

C$11.95 (+1.96%)

Earnings
KP Tissue Inc Annual Shareholders Meeting Transcript
Jun 04, 2020
Q1 2020 KP Tissue Inc Earnings Call Transcript
May 08, 2020

C$9.97 (-2.06%)

Earnings
Q4 2019 KP Tissue Inc Earnings Call Transcript
Mar 12, 2020

C$10.05 (-9.30%)

Earnings
Q3 2019 KP Tissue Inc Earnings Call Transcript
Nov 07, 2019

C$9.27 (+6.06%)

Earnings
Q2 2019 KP Tissue Inc Earnings Call Transcript
Aug 08, 2019

C$8.19 (+0.37%)

Earnings
Q1 2019 KP Tissue Inc Earnings Call Transcript
May 10, 2019

C$7.86 (-1.50%)

Earnings
Q4 2018 KP Tissue Inc Earnings Call Transcript
Mar 07, 2019

C$8.67 (-4.62%)

Earnings

Q2 2021 KP Tissue Inc Earnings Call Transcript

Aug 12, 2021 / 12:30PM GMT

Release Date Price: C$10.24 (-0.58%)

Transcript

Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to KP Tissue Second Quarter 2021 Results Conference Call. (Operator Instructions) Before turning the meeting over to management, I would like to remind everyone that this conference call is being recorded on Thursday, August 12, 2021.

I will now turn the conference over to Mike Baldesarra, Director, Investor Relations. Please go ahead.

Mike Baldesarra

KP Tissue Inc. - Director of IR

Thank you, operator, and good morning, ladies and gentlemen. My name is Mike Baldesarra. I'm the Director of Investor Relations for KP Tissue Inc. The purpose of this conference call is to review the financial results for the second quarter of 2021 for Kruger products L.P., which I'll refer to as KPLP going forward. With me this morning is Dino Bianco, Chief Executive Officer of KP Tissue and Kruger Products L.P.; and Mark Holbrook, the Chief Financial Officer of KP Tissue and Kruger Products L.P.

The following discussions and responses to questions contain forward-looking statements

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.